Ventipeep, a new age respirator mask, developed to administer supplemental oxygen (medically referred to as FiO2), is saving thousands of lives in this critical situation, with its capacity to save patients from SPO2 levels of 50%. It is currently being used by more than 137 Hospitals like Nair Hospital, Fortis Hospital, Civil Hospital Surat, Ispat General Hospital, Orange Hospital, Sanjeevani Hospital, Yasfeen Hospital, Rajasthan Hospital, CMD Hospital, A V Hospital amongst others.
The second wave of COVID-19 has lead to an increase in the number of patients needing hospitalization and ICU treatment leading to a major stress on our medical infrastructure, scarcity of beds, ventilators and oxygen supply. As of the first week of April, 2021 there were 4,02,552 active COVID-19 cases in the state of Maharashtra out of which an average of 25% i.e. 1,00,000 patients were entered into ICU’s. However, there are only 11,587 ICU beds and only 5,793 ventilators available.
Ventipeep can be used in the ICU, in the normal wards and even inside ambulances. All it needs is a simple 10 LPM Oxygen concentrator (along with Ventipeep) to help ARDS, ALI, Covid 19 patients or any patient in need of oxygen to stabilise and recover. It is also an excellent aid to small hospitals which lack infrastructure as it helps reduce the time needed for treatment and can be used in any ward of the hospital.
Ventipeep is an affordable device which is cost saving for hospitals and is also time saving as it reduces the number of days of hospitalization of a patient. It can also be used at home as it does not require a trained professional as needed to operate a ventilator. Ventipeep already has received a CTRI number and the device has already received approval from the ethics committee. This ‘miracle product’ as termed by doctors who have obtained positive results on patients through its use, is bringing a new ray of hope of life amidst the catastrophic situation of Covid-19 surge and mortality in India.